Respiratory syncytial virus bronchiolitis: a double-blind dexamethasone efficacy study
- PMID: 9427901
- DOI: 10.1016/s0022-3476(97)70044-1
Respiratory syncytial virus bronchiolitis: a double-blind dexamethasone efficacy study
Abstract
The efficacy of dexamethasone therapy for primary respiratory syncytial virus bronchiolitis was studied in a double-blind placebo design in 29 previously healthy infants (median age, 194 days). No significant differences were found between the groups in evolution of respiratory rate, oxygen saturation, clinical score, or pulmonary function tests on day 3.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
